We are live on ! Find out more
UTMD icon

Utah Medical Products
UTMD

76 hedge funds and large institutions have $159M invested in Utah Medical Products in 2016 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 30 increasing their positions, 22 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

450% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 2

36% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 22

12% more funds holding

Funds holding: 68 → 76 (+8)

1% more capital invested

Capital invested by funds: $158M → $159M (+$1.12M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
76
Holders Change
+8
Holders Change %
+11.76%
% of All Funds
2.03%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
11
Increased
30
Reduced
22
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AI
Analytic Investors
California
+$1.05M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$696K
3
Two Sigma Investments
Two Sigma Investments
New York
+$450K
4
Renaissance Technologies
Renaissance Technologies
New York
+$437K
5
ACM
Ativo Capital Management
Illinois
+$406K

Top Sellers

Rank Fund Capital Flow
1
American Century Companies
American Century Companies
Missouri
-$3.15M
2
NTCM
Nine Ten Capital Management
Illinois
-$1.65M
3
MDCM
Morgan Dempsey Capital Management
Wisconsin
-$822K
4
BFA
BlackRock Fund Advisors
California
-$634K
5
BIP
Brandes Investment Partners
California
-$599K
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
26
Ativo Capital Management
Illinois
$934K +$406K +6,300 +74%
BIM
27
BlackRock Investment Management
Delaware
$899K +$30K +465 +3%
Schroder Investment Management Group
28
Schroder Investment Management Group
United Kingdom
$718K -$38.7K -600 -5%
TCIM
29
TIAA CREF Investment Management
New York
$686K -$11.5K -179 -2%
IP
30
Isthmus Partners
Wisconsin
$647K -$11.4K -177 -2%
Morgan Stanley
31
Morgan Stanley
New York
$625K +$331K +5,136 +107%
Charles Schwab
32
Charles Schwab
California
$611K – – –
NFA
33
Nationwide Fund Advisors
Ohio
$582K -$96.7K -1,500 -14%
Deutsche Bank
34
Deutsche Bank
Germany
$502K +$69.7K +1,080 +16%
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
$454K -$48K -744 -9%
Two Sigma Investments
36
Two Sigma Investments
New York
$440K +$450K +6,985 New
CCMINC
37
Cardinal Capital Management Inc (North Carolina)
North Carolina
$398K +$20.8K +323 +5%
TA
38
Teachers Advisors
New York
$347K – – –
TA
39
Teton Advisors
New York
$326K – – –
WCM
40
Wedge Capital Management
North Carolina
$309K – – –
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$289K +$40.1K +621 +16%
MC
42
Menta Capital
California
$289K +$296K +4,587 New
SCP
43
Seizert Capital Partners
Michigan
$278K -$44.5K -690 -14%
NI
44
Numeric Investors
Massachusetts
$259K +$12.9K +200 +5%
GCP
45
GSA Capital Partners
United Kingdom
$258K +$19.3K +300 +8%
New York State Common Retirement Fund
46
New York State Common Retirement Fund
New York
$252K – – –
PIM
47
Penobscot Investment Management
Massachusetts
$252K – – –
MAM
48
Martingale Asset Management
Massachusetts
$246K +$25.8K +400 +11%
SIM
49
Spark Investment Management
New York
$245K +$252K +3,900 New
Two Sigma Advisers
50
Two Sigma Advisers
New York
$202K +$206K +3,200 New
1
2
3 4

UTMD Hedge Fund Activity: Q2 2016 in Review

76 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q2 2016, worth a combined $159M — up 0.71% from $158M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new UTMD positions and 2 closed out — a net gain of 9 holders — while 30 added to existing stakes and 22 trimmed.

The largest buyer was Analytic Investors, opening a new position worth an estimated $1.05M. The largest seller was American Century Companies, cutting an estimated $3.15M.

  • 76 institutional investors held Utah Medical Products (UTMD) as of Q2 2016, up from 68 in Q1 2016.
  • Funds reported $159M of Utah Medical Products stock for Q2 2016, up 0.71% quarter-over-quarter.
  • 11 funds opened new Utah Medical Products positions in Q2 2016 and 2 closed out, a net change of +9 holders.
  • The largest Utah Medical Products buyer in Q2 2016 was Analytic Investors, an estimated $1.05M added.
  • The largest Utah Medical Products seller in Q2 2016 was American Century Companies, an estimated $3.15M sold.

Based on aggregated 13F filings for Q2 2016.